Life sciences

For our global population of over 8 billion and rising, sustainable food, healthcare and medicines are vital. We work with the life sciences sector to enable essential research and manufacturing to meet demand.

Life sciences

Understanding complexity in life sciences

The life sciences sector is at the forefront of innovation, spanning pharmaceuticals, biomedical technologies, diagnostics and digital health, animal health, agribusiness and more. Like the global population it serves, the sector is growing,

To meet the challenges of globalisation, consumer demands and fierce competition, the sector is retrofitting, expanding and building new facilities. Projects and programmes can be highly complex, with pressurised timescales and costs to deliver on business plan ambitions fast within this intense commercial environment.

Scientific research campuses, buildings, laboratories and production facilities have to comply with exacting technical, safety and regulatory requirements. These demanding large-scale projects may include a range of building types, from offices to energy centres, and require specialised utility services and zones, such as high containment areas and cleanrooms.

Our expertise in life sciences

We have decades of experience in life sciences and pharmaceutical programme delivery. Our global team is made up of genuine experts, many of whom have worked for life sciences companies, giving us a deep understanding of how to navigate the unique and challenging regulatory landscape within this sector.

We fully understand our clients’ evolving business priorities and operating needs. Through our proven early planning approach, which combines technology, experts, and data, we set projects and programmes on course for success, without compromising speed of delivery.

We can call upon an extensive global library of digitised benchmarking data, market-leading digital tools and best practice learning to drive the highest standards of performance.

Major projects and programmes

We are working with 20 of the 25 largest global pharmaceutical organisations, including Eli Lilly, AstraZeneca, Lonza, Novo Nordisk and Takeda.

Depth of experience

Drawing on our experience across 100s of projects and programmes in life sciences, we bring specialist knowledge of the unique requirements of this fast-paced sector.

Global expertise

We have a multi-disciplinary team of 200 life sciences experts, giving us the reach, specialism and local insight to support global mega-programmes.


Learn how we are working with global clients in pharmaceuticals, biomedical technologies and agribusiness to drive value and efficiency in projects and programmes for advanced scientific research and production facilities.

Life sciences services

We help clients meet the challenges of expanding, upgrading or developing facilities, by bringing our experience and expertise to the early stages of project planning.

We support procurement by engaging with the market, to source the most appropriate equipment vendors and suppliers. Our knowledge of the life sciences sector enables us to drive value and performance through robust cost control and project management, while managing and mitigating risk. We understand the importance of validating delivery for business, financial and regulatory reporting processes.

Novo Nordisk thoroughly appreciates the partnership we have with Turner & Townsend. This foundation of trust continues to strengthen by consistent, excellent performance from the team and their in-depth knowledge of pharmaceutical capital project management and controls. Morten Nielsen, Senior Vice President Novo Nordisk

Life sciences contacts